308 related articles for article (PubMed ID: 25179242)
41. Analysis of a splice acceptor site mutation which produces multiple splicing abnormalities in the human argininosuccinate synthetase locus.
Su TS; Lin LH
J Biol Chem; 1990 Nov; 265(32):19716-20. PubMed ID: 2246255
[TBL] [Abstract][Full Text] [Related]
42. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.
Iacobazzi V; Invernizzi F; Baratta S; Pons R; Chung W; Garavaglia B; Dionisi-Vici C; Ribes A; Parini R; Huertas MD; Roldan S; Lauria G; Palmieri F; Taroni F
Hum Mutat; 2004 Oct; 24(4):312-20. PubMed ID: 15365988
[TBL] [Abstract][Full Text] [Related]
43. [ASS1 gene mutation in a neonate with citrullinemia type I].
Xie B; Chen R; Wang J; Luo J; Li W; Chen S
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):788-91. PubMed ID: 25537548
[TBL] [Abstract][Full Text] [Related]
44. Argininosuccinate synthetase deficiency: mutation analysis in 3 Thai patients.
Wasant P; Viprakasit V; Srisomsap C; Liammongkolkul S; Ratanarak P; Sathienkijakanchai A; Svasti J
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):757-61. PubMed ID: 16124451
[TBL] [Abstract][Full Text] [Related]
45. Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1).
Häberle J; Pauli S; Schmidt E; Schulze-Eilfing B; Berning C; Koch HG
Mol Genet Metab; 2003 Nov; 80(3):302-6. PubMed ID: 14680976
[TBL] [Abstract][Full Text] [Related]
46. PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction.
Verma M; Charles RCM; Chakrapani B; Coumar MS; Govindaraju G; Rajavelu A; Chavali S; Dhayalan A
J Mol Biol; 2017 Jul; 429(15):2278-2289. PubMed ID: 28587924
[TBL] [Abstract][Full Text] [Related]
47. [Clinical and ASS1 gene variant analysis of three Chinese pedigrees affected with Citrullinemia type I].
Dong R; Zhang K; Guo H; Zhang G; Lyu Y; Gao M; Gai Z; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Nov; 40(11):1345-1349. PubMed ID: 37906139
[TBL] [Abstract][Full Text] [Related]
48. Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.
Zou Z; Hu X; Luo T; Ming Z; Chen X; Xia L; Luo W; Li J; Xu N; Chen L; Cao D; Wen M; Kong F; Peng K; Xie Y; Li X; Ma D; Yang C; Chen C; Yi W; Liu O; Liu S; Luo J; Luo Z
Nat Commun; 2021 Apr; 12(1):2263. PubMed ID: 33859183
[TBL] [Abstract][Full Text] [Related]
49. Application of mutation analysis for the previously uncertain cases of adult-onset type II citrullinemia (CTLN2) and their clinical profiles.
Tanaka T; Nagao M; Tsutsumi H
Tohoku J Exp Med; 2002 Oct; 198(2):89-97. PubMed ID: 12512993
[TBL] [Abstract][Full Text] [Related]
50. Genomic structure of the adult-onset type II citrullinemia gene, SLC25A13, and cloning and expression of its mouse homologue.
Sinasac DS; Crackower MA; Lee JR; Kobayashi K; Saheki T; Scherer SW; Tsui LC
Genomics; 1999 Dec; 62(2):289-92. PubMed ID: 10610724
[TBL] [Abstract][Full Text] [Related]
51. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
52. A nonsense mutation is responsible for the RNA-negative phenotype in human citrullinaemia.
Li CM; Chao HK; Liu YF; Su TS
Eur J Hum Genet; 2001 Sep; 9(9):685-9. PubMed ID: 11571557
[TBL] [Abstract][Full Text] [Related]
53. The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemia.
Dimmock DP; Trapane P; Feigenbaum A; Keegan CE; Cederbaum S; Gibson J; Gambello MJ; Vaux K; Ward P; Rice GM; Wolff JA; O'Brien WE; Fang P
Am J Med Genet A; 2008 Nov; 146A(22):2885-90. PubMed ID: 18925679
[TBL] [Abstract][Full Text] [Related]
54. A novel Romani microdeletion variant in the promoter sequence of
Imagawa E; Diaz GA; Oishi K
Mol Genet Metab Rep; 2020 Sep; 24():100619. PubMed ID: 32637322
[TBL] [Abstract][Full Text] [Related]
55. Identification of Novel Mutations in Chinese Infants With Citrullinemia.
Cheng Z; He X; Zou F; Xu ZE; Li C; Liu H; Miao J
Front Genet; 2022; 13():783799. PubMed ID: 35309121
[TBL] [Abstract][Full Text] [Related]
56. Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes.
Perez CJ; Jaubert J; Guénet JL; Barnhart KF; Ross-Inta CM; Quintanilla VC; Aubin I; Brandon JL; Otto NW; DiGiovanni J; Gimenez-Conti I; Giulivi C; Kusewitt DF; Conti CJ; Benavides F
Am J Pathol; 2010 Oct; 177(4):1958-68. PubMed ID: 20724589
[TBL] [Abstract][Full Text] [Related]
57. Citrullinemia Type 1: Behavioral Improvement with Late Liver Transplantation.
Janwadkar A; Shirole N; Nagral A; Bakshi R; Vasanth S; Bagde A; Yewale V; Mirza D
Indian J Pediatr; 2019 Jul; 86(7):639-641. PubMed ID: 30848473
[TBL] [Abstract][Full Text] [Related]
58. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein.
Kobayashi K; Sinasac DS; Iijima M; Boright AP; Begum L; Lee JR; Yasuda T; Ikeda S; Hirano R; Terazono H; Crackower MA; Kondo I; Tsui LC; Scherer SW; Saheki T
Nat Genet; 1999 Jun; 22(2):159-63. PubMed ID: 10369257
[TBL] [Abstract][Full Text] [Related]
59. Molecular characterization of two novel mutations causing factor XI deficiency: A splicing defect and a missense mutation responsible for a CRM+ defect.
Guella I; Soldà G; Spena S; Asselta R; Ghiotto R; Tenchini ML; Castaman G; Duga S
Thromb Haemost; 2008 Mar; 99(3):523-30. PubMed ID: 18327400
[TBL] [Abstract][Full Text] [Related]
60. The 1.6 A crystal structure of E. coli argininosuccinate synthetase suggests a conformational change during catalysis.
Lemke CT; Howell PL
Structure; 2001 Dec; 9(12):1153-64. PubMed ID: 11738042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
